|Bid||17.01 x 1000|
|Ask||19.62 x 1000|
|Day's Range||16.64 - 18.29|
|52 Week Range||12.12 - 65.00|
|Beta (5Y Monthly)||2.74|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The latest analyst coverage could presage a bad day for Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ), with the...
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -50.39% and 60.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
With the business potentially at an important milestone, we thought we'd take a closer look at Arcturus Therapeutics...